Financing
Noncontrolling Interests Activity and Other
Eli Lilly Noncontrolling Interests Activity and Other decreased by 2254.6% to -$591.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.8%, from -$686.00M to -$591.00M. Over 4 years (FY 2021 to FY 2025), Noncontrolling Interests Activity and Other shows a downward trend with a 27.1% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
Metric ID:
pm_noncontrolling_interest_activity_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$14.90M | -$500.00K | -$600.00K | -$282.40M | -$7.60M | -$5.20M | -$13.70M | -$281.00M | -$15.60M | -$6.80M | -$31.60M | -$389.80M | -$8.00M | -$47.30M | -$45.90M | -$686.00M | -$30.70M | -$30.20M | -$25.10M | -$591.00M |
| QoQ Change | — | +96.6% | -20.0% | <-999% | +97.3% | +31.6% | -163.5% | <-999% | +94.4% | +56.4% | -364.7% | <-999% | +97.9% | -491.2% | +3.0% | <-999% | +95.5% | +1.6% | +16.9% | <-999% |
| YoY Change | — | — | — | — | +49.0% | -940.0% | <-999% | +0.5% | -105.3% | -30.8% | -130.7% | -38.7% | +48.7% | -595.6% | -45.3% | -76.0% | -283.8% | +36.2% | +45.3% | +13.8% |
Range-$686.00M – -$500.00K
CAGR+117.0%
Avg YoY Growth-264.7%
Median YoY Growth-42.0%
Noncontrolling Interests Activity and Other at Other Companies
Frequently Asked Questions
- What is Eli Lilly's noncontrolling interests activity and other?
- Eli Lilly (LLY) reported noncontrolling interests activity and other of -$591.00M in Q1 2026.
- How has Eli Lilly's noncontrolling interests activity and other changed year-over-year?
- Eli Lilly's noncontrolling interests activity and other increased by 13.8% year-over-year, from -$686.00M to -$591.00M.
- What is the long-term trend for Eli Lilly's noncontrolling interests activity and other?
- Over 4 years (2021 to 2025), Eli Lilly's noncontrolling interests activity and other has grown at a 27.1% compound annual growth rate (CAGR), from -$295.90M to -$772.00M.